Ipratropium Bromide is a short-acting muscarinic antagonist used primarily via inhalation to treat chronic obstructive pulmonary disease (COPD) and asthma exacerbations by relaxing bronchial smooth muscle.… Read more

![Chemical structure of 8-Isopropyl-8-azabicyclo[3.2.1]oct-3-yl endo-(±)-formylphenylacetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F22235-74-1-8-Isopropyl-8-azabicyclo3.2.1oct-3-yl-endo-formylphenylacetate.png&w=3840&q=75)











Ipratropium Bromide is a short-acting muscarinic antagonist used primarily via inhalation to treat chronic obstructive pulmonary disease (COPD) and asthma exacerbations by relaxing bronchial smooth muscle. Within this category, laboratories find a comprehensive selection of reference standards, including the active pharmaceutical ingredient, process-related impurities, degradation products, and stable isotope labelled compounds. These materials are essential for rigorous quality control and method validation in pharmaceutical settings. Scientists utilize these standards for precise impurity profiling and stability testing, ensuring that formulations meet strict regulatory requirements and pharmacopeial specifications. By providing structurally characterized analogs and metabolites, this collection facilitates the accurate identification and quantification of potential contaminants, supporting the maintenance of high standards for product safety, therapeutic efficacy, and compliance with guidelines for pharmaceutical development.